{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.30","upperLimit":"77.7","value":"33.3"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG002","lowerLimit":"0.4","upperLimit":"64.1","value":"16.7"},{"groupId":"OG003","lowerLimit":"5.2","upperLimit":"40.3","value":"18.2"}]}],"title":"CR"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.4","upperLimit":"64.1","value":"16.7"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG002","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG003","lowerLimit":"0","upperLimit":"15.4","value":"0"}]}],"title":"VGPR"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.3","upperLimit":"77.7","value":"33.3"},{"groupId":"OG001","lowerLimit":"11.8","upperLimit":"88.2","value":"50"},{"groupId":"OG002","lowerLimit":"11.8","upperLimit":"88.2","value":"50"},{"groupId":"OG003","lowerLimit":"7.8","upperLimit":"45.4","value":"22.7"}]}],"title":"PR"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.4","upperLimit":"64.1","value":"16.7"},{"groupId":"OG001","lowerLimit":"0.4","upperLimit":"64.1","value":"16.7"},{"groupId":"OG002","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG003","lowerLimit":"0.1","upperLimit":"22.8","value":"4.5"}]}],"title":"SD"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG001","lowerLimit":"4.3","upperLimit":"77.7","value":"33.3"},{"groupId":"OG002","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG003","lowerLimit":"17.2","upperLimit":"59.3","value":"36.4"}]}],"title":"PD"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"45.9","value":"0"},{"groupId":"OG002","lowerLimit":"4.3","upperLimit":"77.7","value":"33.3"},{"groupId":"OG003","lowerLimit":"0","upperLimit":"15.4","value":"0"}]}],"title":"Missing"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"35.9","upperLimit":"99.3","value":"83.3"},{"groupId":"OG001","lowerLimit":"11.8","upperLimit":"88.2","value":"50"},{"groupId":"OG002","lowerLimit":"22.3","upperLimit":"95.7","value":"66.7"},{"groupId":"OG003","lowerLimit":"20.7","upperLimit":"63.7","value":"40.9"}]}],"title":"ORR (CR+VGPR+PR)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"22"}],"units":"Participants"}],"description":"Best response and overall response rate per the criteria investigator uses for each disease histology. Standardized response and progression criteria is based on established criteria for B-cell malignancies, including WM (Cheson 2014; Owen 2013; Hallek 2008; Bladé 1998; and Durie 2006).","dispersionType":"95% Confidence Interval","groups":[{"description":"Part 1 Cohort 1: ACP-196 100 mg BID + ACP-319 25 mg BID continuously","id":"OG000","title":"Part 1 Cohort 1"},{"description":"Part 1 Cohort 2: ACP-196 100 mg BID + ACP-319 50 mg BID continuously","id":"OG001","title":"Part 1 Cohort 2"},{"description":"Part 1 Cohort 3: ACP-196 100 mg BID + ACP-319 100 mg BID continuously","id":"OG002","title":"Part 1 Cohort 3"},{"description":"Part 2: ACP-196 100 mg BID + ACP-319 50 mg BID continuously","id":"OG003","title":"Part 2"}],"paramType":"NUMBER","populationDescription":"All-Treated Population","reportingStatus":"POSTED","timeFrame":"from the start of the treatment to the last evaluable disease assessment, an average of 1 year","title":"Best Response and Overall Response Rate","type":"PRIMARY","unitOfMeasure":"percentage of participants"}